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AmpoulesAbstract Four simple and sensitive spectrophotometric methods were developed for the determi-
nation of the sulfhydryl containing drug mesna (MSN). Methods I and II rely on nucleophilic
aromatic substitution reactions using two UV tagging reagents namely: 4-chloro-7-nitrobenzo-2-o
xa-1,3-diazole (NBD-Cl) for method I and 2,4-dinitroﬂuorobenzene (DNFB) for method II. Both
reactions took place in alkaline buffered medium and the obtained yellowish products were mea-
sured at 414 and 332 nm for methods I and II, respectively. Methods III and IV are indirect spec-
trophotometric methods based on the suppressive effect of MSN on the absorption of two ternary
complex systems which are composed of 1,10-phenanthroline, silver and eosin for method III and
1,10-phenanthroline, silver and bromopyrogallol red for method IV. The decrease in absorbance of
the ternary complexes was measured at 547 and 635 nm for methods III and IV, respectively. All the
experimental parameters affecting these reactions were carefully studied and optimized. The meth-
ods were validated as per the ICH guidelines. The methods were applicable in the linearity ranges
4–18 lg/mL for method I, 4–16 lg/mL for method II, 0.25–2.25 lg/mL for method III and
0.25–1.75 lg/mL for method IV. The proposed methods were successfully applied for the analysis
of MSN in its commercial ampoules and no interference was encountered from the present excipi-
ents as indicated by the satisfactory percentage recoveries. The results obtained were in a good
agreement with those obtained from a previously published method of the investigated drug.
 2015 Publishing services provided by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Mesna (MSN; Fig. 1) is chemically known as sodium
2-sulfanylethanesulfonate.1 It is an antioxidant used for the
prevention of urothelial toxicity in patients being treated with
the antineoplastics ifosfamide or cyclophosphamide. In the
kidney, dimesna, the inactive metabolite of mesna, is reduced
to free mesna. This has thiol group that reacts with the
metabolites of ifosfamide and cyclophosphamide, including
acrolein, which are considered to be responsible for the toxic
HS
SO3Na
MSN
Figure 1 Chemical structure of mesna (MSN).
22 R.S. Haggag et al.effects on the bladder. MSN is also used as a mucolytic in the
management of some respiratory-tract disorders.2 Besides
these indications, MSN was found to be effective in the treat-
ment of intestinal inﬂammation probably by scavenging reac-
tive oxygen species.3 Moreover, recent studies on MSN have
shown that its antioxidant and antiﬁbrotic properties can be
of potential therapeutic value in protecting the liver against
ﬁbrosis and oxidative injury due to biliary obstruction.4
Because of the increased interest in using MSN for treating
various disorders, it was assumed that its quantitative determi-
nation would be of signiﬁcant importance in clinical practice.
MSN is ofﬁcial in both BP 20131 and USP 34,5 both describe
an indirect iodimetric titration method for the determination
of the drug in its pure powder form. Screening the literature
revealed various techniques that were used for MSN
quantitation. Of these we can mention: a kinetic spectroﬂuori-
metric method using cerium(IV) as an oxidizing agent,6 and
different spectrophotometric methods utilizing several reagents
such as potassium permanganate,7 methyl orange and congo
red,8 N,N-dimethyl-p-phenylenediamine9 and ferric solution.10
Other techniques include high performance liquid chromatog-
raphy (HPLC),11–13 capillary electrophoresis (CE)12 and
Raman spectroscopy.14 In biological ﬂuids, most of the
methods published for MSN quantitation were based on
HPLC.15–17
The aim of this work was to develop simple, sensitive,
reliable and inexpensive spectrophotometric methods for
MSN quantitation in bulk form and in its commercial
ampoules. Methods I and II depend on the reaction of MSN
with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) and
2,4-dinitroﬂuorobenzene (DNFB) in borate buffer, to yield
yellowish colored condensation products which were measured
at their kmax. Methods III and IV involve two indirect
spectrophotometric methods based on the suppressive effect
of MSN on the absorbance of two ternary complexes: 1,10-
phenanthroline, silver and eosin [(phen-Ag-phen)+]2TBF2
for method III and 1,10-phenanthroline, silver and bromopyro-
gallol red [(phen-Ag-phen)+]2BPR2 for method IV. The
decrease in absorbance of the ternary complexes was found
to be proportional to the drug concentration. All the experi-
mental conditions affecting these reactions were studied and
optimized.2. Experimental
2.1. Instrumentation
 Specord S600 spectrophotometer, associated with WinAs-
pect software version 2.3, Analytik Jena AG, Germany. A
1-cm quartz cell (Analytik Jena) was used.
 A thermostatically controlled water bath, Kӧttermann,
Germany. J.P. SELECTA, S.A. sonicator, Spain.
 Digital pH meter 3310 Jenway.
2.2. Materials and reagents
 All solvents, chemicals and reagents were of pure analytical
grade.
 Pharmaceutical grade of MSN was purchased from Fluka
(Sigma Aldrich, St. Louis, USA). It was certiﬁed to contain
99.04%.
 4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) 98%,
(purchased from Sigma, St. Louis, USA) was prepared as
0.1% w/v solution in methanol. The reagent was stable
for two weeks if kept under refrigeration.
 2,4-Dinitroﬂuorobenzene (DNFB) (Hopkin and Williams
Co., Essex-UK) was prepared as 0.2% w/v solution in
methanol. The reagent was freshly prepared and protected
from light.
 Silver nitrate, assay >99% (Fluka, packed in Switzerland)
was used as 5  104 M solution in double distilled water
and it was protected from light.
 1,10-Phenanthroline (Prolabo) was prepared as 1  103 M
solution in warm distilled water.
 Eosin (TBF) (2,4,5,7-tetrabromoﬂuorescein) (Riedel-De
Hae¨n AG) was prepared as 1  104 M aqueous solution.
 Bromopyrogallol red (BPR) (Aldrich Chem. Co.). Its solu-
tion was prepared by dissolving 25 mg of BPR in 100 mL of
1% ammonium acetate. It should be freshly prepared.
 Ethylenediaminetetraacetic acid (EDTA) (Chemajet,
Alexandria, Egypt) was prepared as 0.1 M aqueous solution.
 Gelatin (Veb Laborchemie Apolda, Germany) was pre-
pared as 0.5 g% solution in warm distilled water.
 Borate buffer (disodium tetraborate) (Gateway Co., Egypt)
was prepared as 0.05 M aqueous solution.
 Boric acid (Gomhouria Co., Alexandria, Egypt) was pre-
pared as 0.1 M solution in warm distilled water.
 Sodium acetate (El. Nasr Pharmaceutical Chemicals Co.
Egypt) was prepared as 1 M aqueous solution.
 NaOH (FEMICO Co., Alexandria, Egypt) was prepared as
0.1 and 1 M aqueous solutions.
 Acetic acid (El. Nasr Pharmaceutical Chemicals Co. Egypt)
was prepared as 10% aqueous solution.
 Methanol (SDFCL, Mumbai, India).
 Fresh double distilled water was used.
2.3. Pharmaceutical preparation
Uromitexan ampoules (Batch No. 3A109A) are manufac-
tured by Baxter oncology GmbH, Germany. The ampoules
are labeled to contain 400 mg mesna/4 mL ampoule.
2.4. Standard stock solutions
For methods I and II, a stock solution of MSN was pre-
pared as 20 mg% in methanol. While for methods III and
IV, it was prepared as 12.5 mg% solution in methanol then
it was diluted to obtain a working solution of ﬁnal concen-
tration 1.25 mg%. These stock solutions were stored in the
refrigerator at 4 C.
Spectrophotometric determination of mesna 232.5. General procedure and construction of the calibration curves
2.5.1. Methods I and II
Accurate volumes from MSN standard stock solution (20 mg
%) (0.2–0.9 mL) for method I and (0.2–0.8 mL) for method
II (in 0.1 mL increments) were transferred into two sets of
10 mL volumetric ﬂasks. The speciﬁed volume of borate buffer
of the optimum pH was added, followed by the appropriate
volume of NBD-Cl (Method I) or DNFB (Method II)
(Table 1). The reaction mixtures were mixed and left to stand
for 30 min at room temperature. The solutions were completed
to the mark with methanol and the absorbances were mea-
sured at 414 nm (Method I) and 332 nm (Method II) against
a similarly treated blank. The calibration graphs were con-
structed by plotting the absorbance values against their corre-
sponding concentrations.
2.5.2. Methods III and IV
Into two sets of 25 mL volumetric ﬂasks different aliquots
of the standard working solution of MSN (1.25 mg%)
(0.5–4.5 mL) for method III and (0.5–3.5) for method IV (in
0.5 mL increments) were transferred. The appropriate volumes
of the following reagents were successively added with mixing:
silver nitrate (5  104 M), EDTA (0.1 M), gelatin (0.5 g%),
1,10-phenanthroline (1  103 M), sodium acetate of the spec-
iﬁed pH (1 M) and ﬁnally TBF (1  104 M) for method III or
BPR for method IV (Table 2). The solutions were mixed,
allowed to stand at room temperature for ten minutes and then
the ﬂasks were made up to 25 mL with distilled water. The
absorbance values were measured at 547 nm (for Method
III) and at 635 nm (for Method IV) and subtracted from the
corresponding reading of a similarly treated blank. The
decrease in absorbance was plotted as a function of concentra-
tion of the drug to construct the calibration curves.Table 1 Assay parameters for the determination of MSN
using the proposed methods I and II.
Parameters Method I Method II
Borate buﬀer pH 8.5 9.5
Borate buﬀer volume (mL) 0.7 0.5
Reagent volume (mL) 0.8 0.4
Reaction temperature (C) Room temperature
Reaction time (min) 30
Table 2 Assay parameters for the determination of MSN
using the proposed methods III and IV.
Parameters Method III Method IV
Acetate buﬀer pH 7 6.6
Acetate buﬀer volume (mL) 0.4 0.6
Silver nitrate volume (mL) 1.6 1.2
EDTA volume (mL) 1 1
Gelatin volume (mL) 2 4
1,10-Phenanthroline volume (mL) 0.6 0.5
TBF volume (mL) 3.5 —
BPR volume (mL) — 0.6
Reaction time (min) 10
Reaction temperature (C) Room temperature2.6. Procedure for ampoules
2.6.1. Uromitexan ampoule assay: (400 mg mesna/4 mL
ampoule)
The contents of ﬁve ampoules were mixed well and an aliquot
of 1 mL was accurately transferred into a 100 mL volumetric
ﬂask, the volume was completed to the mark with methanol
and the solution was thoroughly mixed to obtain a solution
of concentration 100 mg%. For methods I and II, dilution
was made by transferring 10 mL from the latter solution into
another 50 mL volumetric ﬂask where the volume was adjusted
with methanol. Then, different appropriate aliquots of this
solution were assayed as described under ‘‘General procedure
and construction of the calibration curves” (Section 2.5.1).
For methods III and IV, dilution was done by transferring
12.5 mL from the 100 mg% solution to a 100 mL volumetric
ﬂask and completing to the mark with methanol. The latter
solution was further diluted 10 folds with methanol to obtain
a test solution of concentration 1.25 mg%. Different appropri-
ate aliquots of this diluted solution were then assayed as spec-
iﬁed under ‘‘General procedure and construction of the
calibration curves” (Section 2.5.2).3. Results and discussion
MSN is a non UV absorbing compound that lacks any chro-
mophore in its structure, therefore two strategies were
adopted to render its spectrophotometric analysis feasible:
ﬁrst, by derivatization with chromogenic reagents, or second,
by suppressing the absorbance of silver containing ternary
complexes upon the reaction of –SH group in MSN with sil-
ver ion.
3.1. Methods I and II
In methods I and II, MSN reacted with either NBD-Cl or
DNFB in aqueous alkaline buffered medium through nucle-
ophilic aromatic substitution reaction to yield yellowish con-
densation products that absorb maximally at 414 and
332 nm, respectively (Figs. 2 and 3). The following schemes
present the proposed pathways for the reaction of MSN
with NBD-Cl and DNFB (see Schemes 1 and 2).
3.1.1. Reaction stoichiometry
Job’s method of continuous variation was applied to determine
the reaction stoichiometry between MSN and the two reagents
NBD-Cl and DNFB. This was done by preparing equimolar
concentrations of the drug solution and the two reagents
(1.2  103 M) and adding different volumes of the drug and
each reagent to obtain different ratios of total volume of
1 mL. From Job’s method plots we can conclude that the reac-
tion ratio between MSN/NBD-Cl or between MSN/DNFB is
(1:1) (Fig. 4).
3.1.2. Optimization of the reaction conditions
The reaction conditions were studied through a series of exper-
iments to determine the optimum experimental values that give
maximum and reproducible measurements. The optimized
reaction conditions were summarized in Table 1.
Figure 2 Absorption spectra of the derivative formed between NBD-Cl and 8 lg/mL MSN ( ), NBD-Cl blank solution (. . ..) and
NBD-Cl blank solution acidiﬁed with 0.2 mL of 5 M HCl (- - -).
Figure 3 Absorption spectra of the derivative formed between DNFB and 12 lg/mLMSN ( ), DNFB blank solution (. . ..) and DNFB
blank solution acidiﬁed with 0.2 mL of 5 M HCl (- - -).
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24 R.S. Haggag et al.3.1.2.1. Effect of buffer pH. The effect of borate buffer pH on
the nucleophilic substitution reactions was studied over the pH
range 7–10.5 (at 0.5 pH unit interval) while keeping all other
parameters constant. In method I, it was found that the absor-
bance intensity of the formed derivative increased slightly at
pH 7.5 and further increase in the buffer pH had no signiﬁcant
effect on the product response (Fig. 5). So pH 8.5 was chosen
for this study. In method II, it is obvious from the same ﬁgure
that below pH 8.5 the formed product had a poor response,but by gradual increase in the buffer pH, the response
increased and reached its maximum value at pH range
8.5–10 then it started to decrease. Therefore, pH 9.5 was
chosen for this method. Other buffers having the same
optimum pH value such as bicarbonate or phosphate buffers
were tried and compared with 0.05 M borate buffer which
proved to be superior to other buffers having the same pH
value owing to the higher absorbance readings obtained in
borate buffer in both methods I and II.
Figure 4 Job’s method of continuous variation plot for the
determination of the stoichiometric ratio between MSN with
NBD-Cl and DNFB.
Figure 6 Effect of borate buffer volume on the substitution
reaction of 4 and 6 lg/mL MSN with NBD-Cl and DNFB,
respectively.
Spectrophotometric determination of mesna 253.1.2.2. Effect of buffer volume. The effect of borate buffer vol-
ume on the absorbance intensity of the formed products was
studied. This was done using different volumes of borate buf-
fer (0.2–0.8 mL) of the optimized pH while keeping all other
factors constant. Fig. 6 shows that the highest absorptions
were achieved using 0.7 and 0.5 mL borate buffer for methods
I and II, respectively.
3.1.2.3. Effect of NBD-Cl and DNFB volume. The effect of
NBD-Cl and DNFB concentrations on the color development
was investigated by trying different volumes from the reagent
stock solution ranging from 0.2 to 1 mL (in 0.2 mL incre-
ments). In method I, it was found that using less than
0.4 mL of this reagent resulted in lower absorption intensity
of the formed derivative. A volume of 0.8 mL of 0.1% w/v
NBD-Cl was chosen as the most appropriate volume
(Fig. 7). For Method II, it was found that 0.4 mL of 0.2%
w/v DNFB were suitable for the reaction; as further increase
in the reagent volume resulted in a gradual decrease in the pro-
duct response (Fig. 7).
3.1.2.4. Effect of reaction time and temperature. The effect of
reaction temperature and time on the nucleophilic substitution
reactions was studied for both methods I and II. This was per-
formed by investigating the effect of four different tempera-
tures (room temperature, 40, 60 and 80 C) at constant time
interval (every 10 min). It was found that the reactionsFigure 5 Effect of borate buffer pH on the substitution reaction
of 4 and 6 lg/mL MSN with NBD-Cl and DNFB, respectively.proceeded at room temperature and attained their maximum
sensitivity after 30 min, whereas heating resulted in non repro-
ducible results and much lower sensitivity (Table 3).
3.1.2.5. Effect of acidification using 5 M HCl. It was reported
that heating NBD-Cl in aqueous methanolic buffer resulted
in the appearance of two absorption bands with maxima at
372 and 462 nm. These two bands correspond to the formation
of NBD-OCH3 and its hydrolysis product NBD-OH. Acidiﬁ-
cation of a solution containing NBD-OH results in a hyp-
sochromic shift of its absorption band from 462 to 387 nm.
This shift was attributed to the protonation of the dissociated
hydroxyl group of NBD-OH.18 Thus it was concluded that
heating NBD-Cl is the main reason of appearance of these
products and the increase in the background readings. In our
study, MSN reacted with NBD-Cl at room temperature, thus
the acidiﬁcation step was of no need.
For DNFB, it has been reported that the excess reagent
must be hydrolyzed to 2,4-dinitrophenol by acidiﬁcation to
get rid of the excess reagent spectral interference.19 But in some
published methods the acidiﬁcation step was omitted, as it did
not affect the absorbance signiﬁcantly.20 In our study, we
investigated the effect of acidiﬁcation by comparing the absor-
bance value of the blank solution with and without acidiﬁca-
tion at 332 nm (kmax of the reaction product; Fig. 3). It is
clear that acidiﬁcation led to a small decrease in the blank
readings, which could be easily eliminated through the instru-
mental background correction (auto zero of blank); so theFigure 7 Effect of NBD-Cl and DNFB volumes on their
substitution reaction with 4 and 6 lg/mL MSN, respectively.
Table 3 Effect of reaction temperature and time on the absorbance of the products obtained from the reactions of NBD-Cl and
DNFB with MSN in borate buffer medium.
Time (min) Temperature (C)
Method I Method II
Room temperature 40 C 60 C 80 C Room temperature 40 C 60 C 80 C
10 0.335 0.330 0.329 0.329 0.338 0.289 0.257 0.250
20 0.354 0.325 0.341 0.315 0.346 0.233 0.249 0.227
30 0.367 0.333 0.316 0.333 0.370 0.309 0.260 0.264
40 0.363 0.348 0.324 0.290 0.369 0.235 0.220 0.248
Figure 8 Absorption spectrum of the ternary complex [(phen-
Ag-phen)+]2TBF2 solution in the absence (. . .. . .) and in the
presence of 1 lg/mL MSN ( ).
Figure 9 Absorption spectrum of ternary complex [(phen-Ag-
phen)+]2BPR2 solution in the absence (. . .. . .) and in the
presence of 0.7 lg/mL MSN ( ).
26 R.S. Haggag et al.acidiﬁcation step has been omitted to render the procedure
simpler.
3.1.2.6. Stability of the colored product. It was found that the
color of the formed derivatives was stable for at least 60 min.
3.2. Methods III and IV
The use of ternary complexes in quantitative analysis is wide-
spread. A large number of possible combinations between
reagents are capable of forming different ternary complex sys-
tems. These complexes can be utilized in various analytical ﬁelds;
spectrophotometry21,22 and ﬂuorimetry.23,24 In the present
work, two ternary complexes were chosen for the quantitation
of MSN namely: 1,10-phenanthroline, silver and eosin [(phen-
Ag-phen)+]2TBF2 (Method III) and 1,10-phenanthroline, sil-
ver and bromopyrogallol red [(phen-Ag-phen)+]2BPR2
(Method IV).
When increasing amounts of the sulfhydryl containing drug
were added to each complex, a proportional decrease in the
color of the complexes was observed. The reason for this is
that the –SH group in MSN reacted with silver ion present
in the complexes causing the ﬁxation of silver as silver mercap-
tide. As a result, the concentration of silver ion available for
the formation of the ternary complexes decreased. This causes
a concomitant decrease in the absorbance of the solutions
which is proportional to MSN concentration.25 Figs. 8 and 9
show the absorption spectra of the two ternary complexes
formed in the absence and in the presence of MSN. The reac-
tion mechanisms are proposed in Scheme 3.
As these spectrophotometric methods depend on the forma-
tion of ternary complexes, they are subjected to interference
from foreign ions: ions which would interfere by reacting with
BPR, with TBF, with 1,10-phenanthroline or with all of them.
For this reason 1 mL of 0.1 M EDTA solution was added to
all samples to suppress the interference of any extraneous ions.
The reaction of MSN with the two ternary complexes is not
affected by the presence of EDTA. Therefore, it could be pos-
sible to determine MSN in the presence of very large excess of
interfering ions provided that they form reasonably stable
EDTA complexes at pH 7 and 6.6, and these complexes don’t
absorb appreciably at the wavelengths of detection.26–28
3.2.1. Optimization of the reaction conditions
The different experimental parameters were optimized in order
to achieve maximum suppressive effect of MSN on the absor-
bance of the two ternary complexes. The optimum conditions
are summarized in Table 2.3.2.1.1. Effect of buffer pH. In many previous reports it was
found that the maximum suppressive effect of the drugs on
the absorbance of these ternary complexes is attained at pH
range 6–8.25,29,30 In addition, using more alkaline buffers
increases the incidence of BPR oxidation which becomes
appreciable at pH > 9.26 So the inhibition effect of MSN
was investigated within this pH range. The best results were
obtained using acetate buffer of pH 7 and 6.6 for methods
III and IV, respectively (Fig. 10).
i)  [(phen-Ag -phen)+]2 . TBF 2- +  RSH                RS      Ag  + TBFH-  +
          (phen-Ag-phen)+ + 2 phen + [(phen-Ag -phen)+]2 . TBF 2-
ii) [(phen-Ag -phen)+]2 . BPR 2- +  RSH                 RS       Ag  + BPRH-  +
                              (phen-Ag-phen)+ + 2 phen + [(phen-Ag -phen)+]2 . BPR 2-
MSN     R= CH2-CH2-SO3 Na 
Scheme 3 Proposed pathway for the reaction of MSN with the two ternary complexes.
Figure 10 Effect of buffer pH on the reaction of [(phen-Ag-
phen)+]2TBF2 and [(phen-Ag-phen)+]2BPR2 with 1.2 and
0.7 lg/mL MSN, respectively.
Figure 12 Effect of gelatin volume on the reaction of [(phen-Ag-
phen)+]2TBF2 and [(phen-Ag-phen)+]2BPR2 with 1.2 and
0.7 lg/mL MSN, respectively.
Spectrophotometric determination of mesna 273.2.1.2. Effect of buffer volume. The effect of acetate buffer vol-
ume on the decrease in blank absorbance was studied. The buf-
fer volume was varied from 0.2 to 1 mL (in 0.2 mL increments)
while keeping all other parameters constant. The study
revealed that the maximum absorption subtraction signal is
reached when using 0.4 and 0.6 mL of acetate buffer for
methods III and IV, respectively (Fig. 11).
3.2.1.3. Effect of gelatin volume. The ternary complex color
systems are unstable (owing to their colloidal nature), a pink
precipitate (in case of [(phen-Ag-phen)+]2TBF2) or blue pre-
cipitate (in case of [(phen-Ag-phen)+]2BPR2) settles down
on standing. To solve this problem, we found in literatureFigure 11 Effect of buffer volume on the reaction of [(phen-Ag-
phen)+]2TBF2 and [(phen-Ag-phen)+]2BPR 2 with 1.2 and
0.7 lg/mL MSN, respectively.different stabilizing agents were tried such as: triton X-100,
sodium lauryl sulphate, polyvinyl alcohol and sodium
carboxymethylcellulose. The best results were obtained using
gelatin,27,30 it acts as a protective colloid; which solubilizes
the precipitate and produces a clear solution of the two com-
plexes. Moreover, gelatin has to be added before introducing the
dye solutions (TBF or BPR) to obtain more reproducible results.
The effect of gelatin volume on the measured signal was
investigated. In case of method III, the optimum gelatin vol-
ume was found to be 2 mL. Whereas, by increasing the gelatin
volume beyond 3 mL the measured signal started to decrease
(Fig. 12). A volume of 4 mL of gelatin was found to be suitable
for the reaction of MSN with the ternary complex [(phen-Ag-
phen)+]2BPR2 (Method IV), as the measured signal was
poor using gelatin volumes less than 2 mL (Fig. 12).Figure 13 Effect of silver nitrate volume on the reaction of
[(phen-Ag-phen)+]2TBF2and [(phen-Ag-phen)+]2BPR2 with
1.2 and 0.7 lg/mL MSN, respectively.
Figure 14 Effect of phenanthroline volume on the reaction of
[(phen-Ag-phen)+]2TBF2 and [(phen-Ag-phen)+]2BPR2 with
1.2 and 0.7 lg/mL MSN, respectively.
Figure 16 Effect of BPR volume on the formation of the ternary
complex [(phen-Ag-phen)+]2BPR2.
28 R.S. Haggag et al.3.2.1.4. Effect of silver nitrate volume. Silver nitrate concentra-
tion is an important factor in our study. Its volume was varied
from 1.4 to 2.4 mL (Method III) and from 1 to 2 mL (Method
IV), in 0.2 mL increments while keeping all other parameters
constant. It was found that 1.6 and 1.2 mL of silver nitrate
were the optimal volumes for the reaction of MSN with
[(phen-Ag-phen)+]2TBF2 and [(phen-Ag-phen)+]2BPR2,
respectively (Fig. 13).
3.2.1.5. Effect of 1,10-phenanthroline concentration. Phenan-
throline participates in the constitution of the two ternary
complexes. Thus studying the effect of its concentration on
the absorption subtraction signal was of considerable impor-
tance. The volume of 1,10-phenanthroline was varied from
0.3 to 1 mL (in 0.1 mL increments) and it was found that 0.6
and 0.5 mL of this reagent are suitable for method III and
method IV, respectively (Fig. 14).
3.2.1.6. Effect of TBF and BPR volumes. The effect of TBF and
BPR volumes was studied in order to obtain maximum and
reasonable blank readings. TBF concentration was studied
by varying its volume from 2 to 5 mL in 0.5 mL increments.
It was found that the maximum blank reading was reached
after the addition of 3 mL and further addition of TBF gave
a plateau. Therefore, three and half milliliters of TBF were
chosen for method III (Fig. 15). BPR concentration was also
studied and its volume was varied from 0.1 to 0.9 mL in
0.1 mL increments. As shown in Fig. 16, the most suitable
BPR volume was 0.6 mL and further increase in its volume
did not affect the absorbance readings.Figure 15 Effect of TBF volume on the formation of the ternary
complex [(phen-Ag-phen)+]2TBF2.3.2.1.7. Effect of reaction time. The suppressive effect of MSN
on the formation of the two ternary complexes was investigated
as a function of time. The solutions were allowed to stand at
room temperature for 70 min and the signal was measured every
5 min through this time interval. It was found that the reaction
between MSN and Ag+ was completed within 10 min. The
absorbance difference remained constant for at least 1 h.
3.3. Validation of the proposed methods
The proposed spectrophotometric methods were validated as
per the International Conference on Harmonization (ICH)
guidelines on validation of analytical procedures.313.3.1. Linearity and concentration ranges
The linearity of the proposed spectrophotometric methods
was evaluated by analyzing a series of different concentra-
tions of the drug with concentration ranges stated in Table 4.
The calibration curves for methods I and II were plotted
using the absorbance intensity of the formed derivatives
against the corresponding concentration of MSN. While for
methods III and IV, calibration curves were constructed as
a function of a decrease in absorbance of the ternary
complexes against the increasing concentration of the drug.
A minimum of ﬁve concentrations is recommended for estab-
lishing the calibration curve. A straight line was obtained in
each case. The obtained results were subjected to statistical
analysis using the least squares method for calculating
correlation coefﬁcients, intercepts, slopes, standard deviation
of intercept (Sa) and slope (Sb) and standard deviation of
residuals (Sy/x). All these validation parameters are summa-
rized in Table 4.
The regression data showed the adherence of the system to
Beer’s law and this was indicated by the high values of corre-
lation coefﬁcients (r> 0.999) and the small values of the inter-
cepts. In addition, deviation around the slopes could be further
calculated by the RSD% of the slopes (Sb%) which were
found to be less than 2%. Linearity can be further guaranteed
by the analysis of variance (ANOVA) test. The F-value is con-
sidered as the most important statistical tool in this test, it is
deﬁned as the ratio of the mean of squares due to regression
divided by the mean of squares due to residuals. The high F
values reveal an increase in the mean of squares due to regres-
sion and a decrease in the mean of squares due to residuals.
Table 4 Regression and statistical parameters for the determination of MSN using the proposed methods.
Parameters Method
Method I Method II Method III Method IV
kmax (nm) 414 332 547 635
Concentration range (lg/mL) 4–18 4–16 0.25–2.25 0.25–1.75
Regression equation
Intercept (a) 2.89  102 2.71  103 2.14  102 1.45  101
Slope (b) 8.78  102 6.08  102 3.3  101 8.31  101
Correlation coeﬃcient (r) 0.9994 0.9994 0.9998 0.9998
Sa
a 1.42  102 1.36  102 4.31  103 7.73  103
Sb
b 1.19  103 1.14  103 3  103 7.06  103
Sy/x
c 1.55  102 1.05  102 5.34  103 9.15  103
RSD% of the slope (Sb%) 1.36 1.88 0.91 0.85
Fd 5410.16 2866.46 12163.97 13837.07
Signiﬁcance F 4.25  1010 1.44  105 1.64  106 3.13  108
LODe (lg/mL) 1.03 1.06 0.07 0.08
LOQf (lg/mL) 3.11 3.22 0.22 0.23
a Standard deviation of the intercept.
b Standard deviation of the slope.
c Standard deviation of the residuals.
d Variance ratio, equals the mean of squares due to regression divided by the mean of squares about regression (due to residuals).
e LOD= Limit of detection.
f LOQ= Limit of quantitation.
Spectrophotometric determination of mesna 29The greater the mean of squares due to regression, the steeper
the regression line. The smaller the mean of squares due to
residuals, the lesser the scatter of the experimental points
around the regression line. Consequently, regression lines with
high F values (low signiﬁcance F) are much better than those
with lower ones. Good regression lines show high values for
both (r) and (F) values.32,33
3.3.2. Detection and quantitation limits
The limit of detection (LOD) is the lowest concentration of the
analyte that can be detected but not necessarily quantitated
under the stated experimental conditions while the limit of
quantitation (LOQ) is the concentration at and above which
the analyte can be reliably quantitated with a previously
deﬁned level of certainty.34 LOD and LOQ of the proposed
spectrophotometric methods were calculated in accordance
to the formulae given by the ICH guidelines, where
LOD= 3.3 S b1 and LOQ= 10 S b1, where S is the stan-
dard deviation of ﬁve blank solutions and b is the slope of
the regression line of the calibration curve. The small values
of LOD and LOQ presented in Table 4 indicate the sensitivity
of the proposed methods.
3.3.3. Accuracy
Accuracy is deﬁned by the International Standards Organiza-
tion (ISO) as ‘the closeness of agreement between a test result
and the accepted reference value of the analyte’.32 The accu-
racy of the proposed methods was studied by applying the
reactions under the speciﬁed optimum conditions at three con-
centration levels of MSN using three replicate determinations
for each concentration.
Accuracy was expressed as recovery% and Er% for MSN,
these values are presented in Table 5 and they conﬁrm the
good accuracy of the proposed methods.3.3.4. Precision
The precision of an analytical method expresses the closeness
of agreement between a series of measurements obtained from
multiple sampling of the same homogenous sample under pre-
scribed conditions.31 It includes repeatability (intra-day preci-
sion) and intermediate precision (inter-day precision).
3.3.4.1. Repeatability (intra-day precision). It expresses preci-
sion under the same operating conditions, over a short interval
of time. Repeatability can be assessed using three different
concentration levels of MSN which were analyzed three times
within the same laboratory, using the same analyst, with the
same equipment, on the same day. RSD% of the obtained
results were calculated and presented in Table 5.
3.3.4.2. Intermediate precision (inter-day precision). It
expresses variations within the same laboratory. Typical vari-
ations to be studied include days, analyst, equipment, etc.
Intermediate precision can be tested using the three different
concentration levels of MSN used in the repeatability study,
these concentration levels were repeated on three different
days, while keeping all other parameters constant. RSD% of
the obtained data was calculated as shown in Table 5.
The percentage relative standard deviation (RSD%) values
from repeatability and intermediate precision were less than
2% proving the high repeatability and precision of the devel-
oped methods for the quantitative estimation of MSN in its
bulk powder form.3.3.5. Robustness
The robustness of an analytical procedure is a measure of its
capacity to remain unaffected by small but deliberate varia-
tions in procedure parameters listed in the procedure docu-
mentation and provides an indication of its suitability during
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30 R.S. Haggag et al.normal usage.31 Robustness of methods I and II was evaluated
by introducing small variations in reagent volume
(±0.05 mL), reaction time (±5 min) and k of detection
(kmax ± 4 nm). For methods III and IV, small deliberate vari-
ations were introduced in silver nitrate volume (±0.2 mL),
gelatin volume (±0.5 mL) and reaction time (±5 min). This
study demonstrated that slight intended variations in the pre-
viously mentioned parameters had no signiﬁcant effect on
MSN determination using the proposed methods. This was
obvious from the low values of RSD% which did not exceed
2% (Table 6).
3.3.6. Selectivity and specificity
Speciﬁcity is deﬁned as the ability to unequivocally asses the
analyte in the presence of components that may be expected
to be present, such as impurities, degradation products and
matrix components.5 The speciﬁcity of the proposed spec-
trophotometric methods could be demonstrated by their abil-
ity to quantify MSN with good accuracy and precision
without interference from co-formulated excipients as indi-
cated by the good percentage recoveries, low values of RSD
% and Er% obtained from analyzing Uromitexan
 ampoules
(Table 7). The speciﬁcity of methods I and II was further con-
ﬁrmed by applying these reactions to the co-administered drug
cyclophosphamide. It was found that cyclophosphamide gave
no reaction with NBD-Cl, however, it reacted with DNFB
when used in concentrations above 1 lg/mL and below this
range no interference was encountered. Therefore, the reaction
with NBD-Cl could be applied in clinical studies to determine
MSN in blood samples of patients being treated with the anti-
neoplastic cyclophosphamide with no interference. On the
other hand, the reaction with DNFB could be also applicable
but when the blood level of the antineoplastic is less than
1 lg/mL.
3.4. Stability of solutions
The methanolic stock solution of MSN was found to be stable
for at least two weeks when refrigerated at 4 C.
3.5. Assay of pharmaceutical preparations
The proposed methods were applied for the determination
of MSN in commercial ampoules (Uromitexan ampoule).
The drug was extracted using the same solvent used for
the preparation of the standard stock solution, and then
dilution to volume was made using methanol to reach con-
centration levels within the speciﬁed ranges. The procedures
were applied following the establishment of all the experi-
mental conditions. Five replicate determinations were made
for each method and the percentage recoveries were calcu-
lated using single point quantiﬁcation or from the linear
regression equations. Also, the SD, RSD% and Er% were
calculated and satisfactory results were obtained for each
method and they were in a good agreement with the label
claim (Table 7). The results obtained were statistically com-
pared with those of a reported spectrophotometric method7
(utilizing alkaline potassium permanganate) using the Stu-
dent’s t-test (for accuracy) and the variance ratio F-test
(for precision). The results in Table 7 show that the t- and
F-values were smaller than the critical values at 95%
Table 6 Evaluation of the robustness of the proposed methods for the determination of MSN.
Parameters Mean% recovery SD RSD (%) Mean% recovery SD RSD (%)
Method I Method II
Reagent volume (±0.05 mL) 99.23 1.20 1.21 98.88 1.73 1.75
Reaction time (±5 min) 98.87 1.45 1.47 99.09 0.53 0.53
k of detection (kmax ± 4 nm) 99.85 0.52 0.52 99.34 1.19 1.20
Method III Method IV
Silver nitrate volume (±0.2 mL) 100.79 0.39 0.39 100.00 0.69 0.69
Gelatin volume (±0.5 mL) 98.73 0.70 0.71 97.53 0.07 0.07
Reaction time (±5 min) 99.16 1.15 1.16 100.60 0.24 0.24
Table 7 Assay results for the determination of MSN in its pharmaceutical preparation using the proposed and reference methods.
Uromitexan ampoule Method I Method II Method III Method IV Reference method7,e
Mean% recovery ± SDa 101.25 ± 0.61 99.89 ± 0.70 101.60 ± 1.76 100.33 ± 1.78 100.31 ± 0.74
RSD% b 0.60 0.70 1.73 1.77 0.74
Er (%)
c 1.25 0.11 1.60 0.33 0.31
t d 2.20 0.92 1.51 0.03 —
F d 1.44 1.12 5.74 5.88 —
a Mean% recovery ± SD of ﬁve determinations.
b % Relative standard deviation.
c % Relative error.
d Theoretical values for t-test and F-test are 2.31 and 6.39, respectively at 95% conﬁdence limit.
e Kinetic spectrophotometric determination of mesna using alkaline potassium permanganate.7
Spectrophotometric determination of mesna 31conﬁdence level, indicating that there were no signiﬁcant
differences between the proposed methods and the reported
one regarding accuracy and precision.
By comparing the four proposed methods with each other
we can conclude that methods I and II are simpler, need less
experimental work regarding reagent preparation and proce-
dure, in addition, their selectivity was proven by analyzing
MSN in the presence of the co-administered drug cyclophos-
phamide. However, methods III and IV are more advanta-
geous concerning the total time of analysis (10 min vs 30 min
for methods I and II), they are more sensitive as demonstrated
by the lower values of LOD and LOQ (Table 4), in addition,
they are environmentally friendly as all the reagents were pre-
pared as aqueous solutions and distilled water was used as the
diluting solvent.
4. Conclusion
In this work, four simple sensitive spectrophotometric meth-
ods were developed for the determination of MSN in bulk
powder and in commercial ampoules. The proposed meth-
ods are characterized by being highly sensitive, simple and
reliable. Sensitivity was illustrated by the low values of
LOD and LOQ. Simplicity was demonstrated by the absence
of extraction procedures. Reliability was guaranteed by the
results obtained from testing various validation parameters
and the successful application to commercial dosage form.
Also, the proposed methods are considered to be economic;
with low solvent consumption and they could be applied in
quality control laboratories where modern equipments are
not available. The absence of interference from added
excipients is a noted advantage. In addition, reproducibility,accuracy and rapidity of the methods enabled them to be used
for the routine determination of MSN in any laboratory.
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